SAPROPTERIN

sapropterin dihydrochloride 100 mg soluble tablet, 30

SAPROPTERIN (11691H)

sapropterin dihydrochloride 100 mg soluble tablet, 30
11691H
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Hyperphenylalaninaemia (HPA) due to phenylketonuria (PKU)
Treatment phase: First continuing treatment

Restriction

Indication: Hyperphenylalaninaemia (HPA) due to phenylketonuria (PKU)
Treatment phase: Subsequent continuing
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 6 Max qty units: 180 # of repeats: 5 DPMQ: $4,819.80 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Kuvan